Efficacy and safety of maintenance therapy with pamiparib versus placebo for advanced gastric cancer responding to first-line platinum-based chemotherapy: Phase 2 study results.
Fortunato CiardielloYung-Jue BangAndrés CervantesMikhail DvorkinCharles D LopezJean-Philippe MetgesAntonio Sánchez RuizMariona CalvoAndrew H StricklandGeorge KannourakisKei MuroHiasto KawakamiJia WeiChristophe BorgZhaoyin ZhuNeal GuptaRobert J PelhamLin ShenPublished in: Cancer medicine (2023)
Maintenance pamiparib did not meet statistical significance for superiority versus placebo for PFS, but was well tolerated with few treatment discontinuations; no unexpected safety signals were identified.